Lv31
400 积分 2025-10-18 加入
早期（Ⅰ-Ⅱ期）子宫内膜癌预后相关因素分析
40分钟前
已关闭
Distinct clinical outcomes according to molecular subgroups in relapsed endometrial carcinoma: A cohort study
8个月前
已完结
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929)
1年前
已完结
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
1年前
已完结
Iparomlimab and Tuvonralimab: First Approval
1年前
已完结
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
1年前
已完结
PD-1 and Its Ligands in Tolerance and Immunity
1年前
已完结
Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer
1年前
已完结
Cancer of the cervix uteri
1年前
已完结
Pembrolizumab for the treatment of cervical cancer
1年前
已完结
皖公网安备34019202002308
